Related Experiment Video

Updated: Feb 14, 2026

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.2K

Updates on Device-Based Therapies for Patients with Heart Failure

Jad Al Danaf1, Javed Butler2, Amin Yehya3

  • 1Division of Cardiovascular Medicine, Department of Internal Medicine, University of Utah, 30 N. 1900E, Room 4A100, Salt Lake City, UT, 84112, USA. jad.aldanaf@hsc.utah.edu.

Current Heart Failure Reports
|February 19, 2018
PubMed

Insights

Device-based therapies are crucial for reducing heart failure morbidity and mortality. Recent trials in 2017 highlight advancements in defibrillators, monitoring, and ventricular assist devices, necessitating further research.

Area of Science:

  • Cardiology and Cardiovascular Devices
  • Heart Failure Management

Background:

  • Heart failure represents a significant and growing global health challenge.
  • While optimal medical therapy is foundational, device-based interventions offer substantial benefits in reducing patient morbidity and mortality.

Purpose of the Study:

  • To review major device-related clinical trials published in 2017 concerning heart failure management.
  • To explore the impact of device therapies on heart failure outcomes and identify areas for future research.

Main Methods:

  • Review of pivotal device-related clinical trials from 2017.
  • Focus on trials involving implantable cardioverter-defibrillators, hemodynamic monitoring, remote monitoring systems, autonomic nervous system modulation, ventricular assist devices, and device-based management of valvular heart disease.

Main Results:

  • Significant advancements were observed across various device categories in 2017.
  • These trials contribute to a better understanding of device efficacy in managing heart failure patients.

Conclusions:

  • Device-based therapies are integral to modern heart failure management, complementing medical treatments.
  • Continued research and clinical trials are essential to fully elucidate the long-term mortality and morbidity benefits, as well as cost-effectiveness, of these advanced therapies.
Abstract

Keywords:
CRT-DClinical trialsDevice-based therapiesHeart failure reduced ejection fractionHemodynamic monitoringLVAD

More Related Videos

Home-Based Transcranial Direct Current Stimulation Device Development: An Updated Protocol Used at Home in Healthy Subjects and Fibromyalgia Patients11:26

Home-Based Transcranial Direct Current Stimulation Device Development: An Updated Protocol Used at Home in Healthy Subjects and Fibromyalgia Patients

Published on: July 14, 2018

18.0K
Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure04:20

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure

Published on: October 1, 2019

6.3K

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
399
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
958
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
363